These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1035 related items for PubMed ID: 32415579

  • 1. COVID-19 update: Covid-19-associated coagulopathy.
    Becker RC.
    J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
    [No Abstract] [Full Text] [Related]

  • 2. 2020 - Year of COVID-19.
    Lillicrap D, Morrissey JH.
    J Thromb Haemost; 2020 Sep; 18(9):2081. PubMed ID: 32881334
    [No Abstract] [Full Text] [Related]

  • 3. ISTH DIC subcommittee communication on anticoagulation in COVID-19.
    Thachil J, Juffermans NP, Ranucci M, Connors JM, Warkentin TE, Ortel TL, Levi M, Iba T, Levy JH.
    J Thromb Haemost; 2020 Sep; 18(9):2138-2144. PubMed ID: 32881336
    [Abstract] [Full Text] [Related]

  • 4. The association between treatment with heparin and survival in patients with Covid-19.
    Ayerbe L, Risco C, Ayis S.
    J Thromb Thrombolysis; 2020 Aug; 50(2):298-301. PubMed ID: 32476080
    [Abstract] [Full Text] [Related]

  • 5. Venous Thromboembolism and Heparin Use in COVID-19 Patients: Juggling between Pragmatic Choices, Suggestions of Medical Societies and the Lack of Guidelines.
    Porfidia A, Pola R.
    J Thromb Thrombolysis; 2020 Jul; 50(1):68-71. PubMed ID: 32367471
    [No Abstract] [Full Text] [Related]

  • 6. A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic.
    Speed V, Patel RK, Byrne R, Roberts LN, Arya R.
    Thromb Res; 2020 Aug; 192():73-74. PubMed ID: 32425265
    [No Abstract] [Full Text] [Related]

  • 7. Deep venous thrombosis in a non-critically ill patient with novel COVID-19 infection.
    Nauka PC, Oran E, Chekuri S.
    Thromb Res; 2020 Aug; 192():27-28. PubMed ID: 32419710
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.
    Ranucci M, Ballotta A, Di Dedda U, Baryshnikova E, Dei Poli M, Resta M, Falco M, Albano G, Menicanti L.
    J Thromb Haemost; 2020 Jul; 18(7):1747-1751. PubMed ID: 32302448
    [Abstract] [Full Text] [Related]

  • 10. Is the type of diabetes treatment relevant to outcome of COVID-19?
    Bloomgarden Z.
    J Diabetes; 2020 Jul; 12(7):486-487. PubMed ID: 32353193
    [No Abstract] [Full Text] [Related]

  • 11. Current Perspectives of Anticoagulation in Patients With COVID-19.
    Gavioli EM, Sikorska G, Man A, Rana J, Vider E.
    J Cardiovasc Pharmacol; 2020 Aug; 76(2):146-150. PubMed ID: 32569013
    [Abstract] [Full Text] [Related]

  • 12. Statins in coronavirus outbreak: It's time for experimental and clinical studies.
    Bifulco M, Gazzerro P.
    Pharmacol Res; 2020 Jun; 156():104803. PubMed ID: 32289478
    [No Abstract] [Full Text] [Related]

  • 13. Revisiting the Protein C Pathway: An Opportunity for Adjunctive Intervention in COVID-19?
    Mazzeffi M, Chow JH, Amoroso A, Tanaka K.
    Anesth Analg; 2020 Sep; 131(3):690-693. PubMed ID: 32541255
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis.
    Thachil J, Longstaff C, Favaloro EJ, Lippi G, Urano T, Kim PY, SSC Subcommittee on Fibrinolysis of the International Society on Thrombosis and Haemostasis.
    J Thromb Haemost; 2020 Sep; 18(9):2408-2411. PubMed ID: 32881272
    [No Abstract] [Full Text] [Related]

  • 16. COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.
    Wanderer JP, Nathan N.
    Anesth Analg; 2020 Nov; 131(5):1323. PubMed ID: 33079849
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach.
    Sarma P, Prajapat M, Avti P, Kaur H, Kumar S, Medhi B.
    Indian J Pharmacol; 2020 Nov; 52(1):1-5. PubMed ID: 32201439
    [No Abstract] [Full Text] [Related]

  • 20. Heparin as a therapy for COVID-19: current evidence and future possibilities.
    Hippensteel JA, LaRiviere WB, Colbert JF, Langouët-Astrié CJ, Schmidt EP.
    Am J Physiol Lung Cell Mol Physiol; 2020 Aug 01; 319(2):L211-L217. PubMed ID: 32519894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.